Search
New Jersey Paid Clinical Trials
A listing of 1666 clinical trials in New Jersey actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
1597 - 1608 of 1666
New Jersey is currently home to 1666 active clinical trials, seeking participants for engagement in research studies. These trials take place at a variety of cities in the state, including New Brunswick, Hackensack, Newark and Morristown. Whether you're a healthy volunteer interested in paid medical research or someone seeking trials related to a specific condition, the state offers a diverse array of opportunities in your vicinity.
Featured Trial
Paid Clinical Studies Nationwide
Recruiting
Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.
Featured Offer
Lose Weight with GLP-1 Medications
Recruiting
Policy Lab has partnered with CareGLP to offer trusted access to GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®.
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $100 off your first program with code policy-lab-100.
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $100 off your first program with code policy-lab-100.
Conditions:
Overweight
Overweight and Obesity
Obesity
Weight Loss
Morbid Obesity
Naltrexone and Propranolol Combined With Immunotherapy
Recruiting
Various forms of stress can promote cancer development and growth and negatively impact the immune system's response to tumors. Beta-adrenergic and opioid receptors co-exist in many cells including immune cells and are integral components of the body's response to stress. Pre-clinical studies have demonstrated that dual blockade of these receptors can decrease tumor growth and modulate the anti-tumor immune response. This clinical trial investigates the safety and potential therapeutic benefits... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
11/14/2023
Locations: Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey
Conditions: Advanced Melanoma
Sleep in Adolescents - Pilot Study
Recruiting
The goal of this pilot clinical trial is to determine the feasibility and acceptability of increasing time in bed to 10 hours per night in children aged 14-17 years. The main question it aims to answer are:
* How much additional sleep short-sleeping-adolescents (\~7h TIB/night) will obtain when asked to increase time-in-bed to 10h/night for seven consecutive nights compared to those who are not asked to increase time-in-bed?
* Are adolescents able to comply with study demands: wearing two devic... Read More
Gender:
ALL
Ages:
Between 14 years and 17 years
Trial Updated:
11/14/2023
Locations: Rutgers Sleep Lab, New Brunswick, New Jersey
Conditions: Sleep
Comparing Targets of Expressive Writing
Recruiting
Expressive writing involves writing about one's deepest thoughts and feelings surrounding an emotional event. The current literature on the efficacy of expressive writing is mixed and warrants further investigation into how, when, and for whom expressive writing is an effective intervention. The goal of this study is to compare the efficacy of expressive writing interventions in young adults when people imagine that they're writing to themselves vs. a loved one. Participants will carry out an ex... Read More
Gender:
ALL
Ages:
Between 18 years and 25 years
Trial Updated:
11/13/2023
Locations: Peretsman Scully Hall, Princeton, New Jersey
An Evaluation of the Yes You Can... Make Smart Choices Curriculum
Recruiting
The New Jersey Physicians Advisory Group (NJPAG) previously created the Yes You Can...Make Smart Choices! (YYC...MSC!) program with the goal of preventing teen pregnancy and enhancing character development in youth. YYC...MSC! is a fully developed intervention that NJPAG has experience implementing that is grounded in a theoretical framework with promising evidence of effectiveness. However, this intervention has not yet undergone a rigorous evaluation with a control or comparison group. This ev... Read More
Gender:
ALL
Ages:
Between 10 years and 21 years
Trial Updated:
11/13/2023
Locations: Arts High School, Newark, New Jersey
Conditions: Adolescent Health, Pregnancy in Adolescence
Palliative Dose Escalated Radiation for Painful Non-Spine Bone Metastases and Painful Non-Bone Metas
Recruiting
The investigators hypothesize that with dose escalation to 40-50 Gy in ten fractions, the complete pain response rate at one month can be increased to 40-50% in painful non-spinal bone metastases. Additionally, the investigators hypothesize that utilizing a fractionation scheme with an escalated biologically equivalent dose (BED) will result in a higher proportion of participants responding to treatment, and will also lead to more durable responses. Furthermore, the investigators hypothesize tha... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
11/12/2023
Locations: RWJBarnabas Health - Robert Wood Johnson University Hospital, Hamilton, New Jersey
Conditions: Neoplasm Metastases, Metastases, Neoplasm
Comparison of High-Dose Rate Brachytherapy and Stereotactic Ablative Radiotherapy as Monotherapy for the Treatment of Localized Prostate Cancer
Recruiting
This phase II trial compares high-dose rate brachytherapy and stereotactic ablative radiotherapy as monotherapy in treating patients with prostate cancer that has not spread to other parts of the body (localized). High-dose rate brachytherapy delivers radiation directly into the prostate within a few minutes by a single radioactive seed through temporarily placed plastic catheters inside the prostate gland. Stereotactic ablative radiotherapy is an external beam radiation method that delivers lar... Read More
Gender:
MALE
Ages:
18 years and above
Trial Updated:
11/09/2023
Locations: RWJBarnabas Health - Saint Barnabas Medical Center, Livingston, Livingston, New Jersey
Conditions: Stage I Prostate Cancer AJCC v8, Stage II Prostate Cancer AJCC v8, Stage IIA Prostate Cancer AJCC v8, Stage IIB Prostate Cancer AJCC v8, Stage IIC Prostate Cancer AJCC v8
Study to Evaluate the Safety of Colchicine
Recruiting
Currently, there are no approved medications for the prevention and treatment of radiation-induced dermatitis, or skin discoloration/burning due to radiation therapy, because there is little evidence to guide treatment.
The purpose of the research is to better understand the factors associated with radiation-induced dermatitis and to explore the efficacy of low-dose colchicine in reducing the proportion of patients with radiation-induced dermatitis who undergo radiation treatment for head and n... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
11/08/2023
Locations: RWJBarnabas Health - Cooperman Barnabas, Livingston, New Jersey
Conditions: Radiation Therapy
Family-Clinician Collaboration to Improve Neglect and Rehabilitation Outcome After Stroke
Recruiting
Spatial neglect may occur in patients who have had a stroke. People with spatial neglect often pay much more attention to one side of the body while ignoring the other side, even though they have no difficulty seeing. The purpose of this study is to evaluate the impact on stroke recovery, including spatial neglect, of the Family-Clinician Collaboration program, where a family member of a stroke survivor actively interacts with clinical staff members providing inpatient rehabilitation services to... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
11/08/2023
Locations: Kessler Foundation, West Orange, New Jersey
Conditions: Stroke, Spatial Neglect
The Nanowear Wearable Covid-19 Observational and Analysis Trend
Recruiting
The NanoCOAT study is a multi-center, prospective, non-randomized, feasibility, observational, non-significant risk study. The NanoCOAT study will enroll a minimum of 10 and a maximum of 100 subjects in a potential for a multi-site in order to collect data and analyze physiological and biometric trends due to Covid-19.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
11/07/2023
Locations: Hackensack University Medical Center, Hackensack, New Jersey
Conditions: Covid19
Assistive Soft Skills and Employment Training (ASSET) in TBI Injury
Recruiting
Pediatric traumatic brain injury (TBI) is often associated with difficulties in social functioning. Loss of social contacts and difficulties maintaining social connections is common after pediatric TBI, extending into adulthood. Social skills are a key aspect of social functioning critical to forming and maintaining social relationships with others, including family, friends, teachers and co-workers. Social skills deficits are thus critical to social participation and overall quality of life. Th... Read More
Gender:
ALL
Ages:
Between 15 years and 25 years
Trial Updated:
10/24/2023
Locations: Kessler Foundation, East Hanover, New Jersey
Conditions: Traumatic Brain Injury
Aim 3, Optimizing CRC Screening in Patients With Diabetes in Safety-net Primary Care Settings
Recruiting
This mixed methods study evaluates the effectiveness and feasibility of a multi-level (patient, team, organizations) intervention to optimize CRC screening for patients with diabetes in primary care safety-net settings.
Gender:
ALL
Ages:
Between 50 years and 74 years
Trial Updated:
10/19/2023
Locations: RWJBarnabas Health - Robert Wood Johnson University Hospital, New Brunswick, New Jersey
Conditions: Colorectal Cancer Screening, Diabetes Mellitus, Type 2
A Clinical Study to Evaluate the Potential Role of ACTH Gel in Patients With Scleritis
Recruiting
ATLAS study is a clinical trial to evaluate the potential role of subcutaneous adrenocorticotropic hormone (ACTH) gel in the management of non-infectious scleritis.
Specifically, the ATLAS Study aims to evaluate the safety, tolerability and effect of 2 different dose regimens of ACTH gel administered by subcutaneous (SC) injection in patients with scleritis, over a period of 12 months.
Scleritis is an inflammatory disease affecting the sclera (white outer coating of the eye), which causes blur... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
10/19/2023
Locations: Metropolitan Eye Research and Surgery Institute, Palisades Park, New Jersey
Conditions: Scleritis